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Abstract
Convergent evidence has suggested a significant effect of antipsychotic exposure on brain structure and function in
patients with schizophrenia, yet the characteristics of favorable treatment outcome remains largely unknown. In this
work, we aimed to examine how large-scale brain networks are modulated by antipsychotic treatment, and whether
the longitudinal changes could track the improvements of psychopathologic scores. Thirty-four patients with first-
episode drug-naïve schizophrenia and 28 matched healthy controls were recruited at baseline from Shanghai Mental
Health Center. After 8 weeks of antipsychotic treatment, 24 patients were re-scanned. Through a systematical dynamic
functional connectivity (dFC) analysis, we investigated the schizophrenia-related intrinsic alterations of dFC at baseline,
followed by a longitudinal study to examine the influence of antipsychotic treatment on these abnormalities by
comparing patients at baseline and follow-up. A structural connectivity (SC) association analysis was further carried out
to investigate longitudinal anatomical changes that underpin the alterations of dFC. We found a significant
symptomatic improvement-related increase in the occurrence of a dFC state characterized by stronger inter-network
integration. Furthermore, symptom reduction was correlated with increased FC variability in a unique connectomic
signature, particularly in the connections within the default mode network and between the auditory, cognitive
control, and cerebellar network to other networks. Additionally, we observed that the SC between the superior frontal
gyrus and medial prefrontal cortex was decreased after treatment, suggesting a relaxation of normal constraints on
dFC. Taken together, these findings provide new evidence to extend the dysconnectivity hypothesis in schizophrenia
from static to dynamic brain network. Moreover, our identified neuroimaging markers tied to the neurobiology of
schizophrenia could be used as potential indicators in predicting the treatment outcome of antipsychotics.
Introduction
Schizophrenia is a severe mental illness characterized by
complex clinical symptoms, including hallucinations,
delusions, and cognitive deficits1. The heterogeneous
characteristics lead to significant challenges for efficacious
treatment. In fact, more than 50% of patients received
antipsychotic drugs fail to relief upon initial treatment2,3
despite some studies reported positive outcomes4,5.
Continuous efforts have been made to understand the
neurobiological mechanisms of antipsychotic action that
lead to favorable treatment outcome. The recent advent of
neuroimaging techniques have highlighted the important
role of brain connectivity in response to antipsychotic
treatment that could serve as potential biomarkers for
treatment assessment. For instance, previous longitudinal
studies in schizophrenia have revealed that the resting-
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state functional connectivity (FC) was increased after
treatment and linked to symptoms improvement6–8.
Other similar studies have suggested that antipsychotic
medications could significantly affect the FC, but altered
connectivity was not associated with the relief of psy-
chotic symptoms9–13. The inconsistency of these findings
may be partially due to an assumption that the functional
couplings between brain regions are static, ignoring the
time-varying properties of FC.
The human brain is known to be highly dynamic14. The
recently-introduced dynamic FC (dFC) is considered to be
an efficient way for uncovering specific functional inte-
gration properties that cannot be discovered through
conventional static FC15–17. Of note, schizophrenia is
beginning to be revealed as abnormalities of dFC18–22.
Specifically, studies using graph theory-based approaches
have revealed a disruption in dFC spatiotemporal effi-
ciency23,24 and temporal variability25,26, which could serve
as potential biomarkers for schizophrenia classification27.
However, only one study, to the best of our knowledge,
has attempted to examine the effects of antipsychotic
exposure on dFC properties of schizophrenia and showed
treatment effects of risperidone on dFC in insular in first-
episode drug-naïve (FEDN) schizophrenia28. It is still
largely unknown how antipsychotic treatment might
modify dynamic patterns in large-scale brain networks
and whether these changes are related to symptomatic
improvement longitudinally.
It is widely accepted that brain function is partially
constrained by its anatomical substrates29,30, with ample
evidence of spatial correspondence between structural
connectivity (SC) and FC31,32. Thus, a comprehensive
understanding of the effects of treatment on dFC should
also consider SC as a scaffold for coordinated neural
activity. For patients with schizophrenia, overlapping
alterations of structure and function have been repeatedly
reported33–36. Additionally, the relationship of SC–FC
within specific networks appears to be absent in patients
with schizophrenia37. Together, these findings suggest
that disruptions of SC–FC coupling are implicated in the
pathophysiology of schizophrenia. To date, no prior study
has applied a combination analysis of SC and dFC to
explore the effects of antipsychotic treatment on large-
scale brain networks of schizophrenia.
The primary aim of this study is to investigate
medication-induced dFC changes in large-scale brain
networks in FEDN schizophrenia related to the relief of
psychotic symptoms. A systematic analysis was performed
to explore the dFC differences at baseline between
patients and controls, followed by a longitudinal study to
determine how altered dFC patterns change in response
to antipsychotic treatment by comparing patients at
baseline and follow-up. Furthermore, we performed an SC
association analysis to examine the longitudinal changes
in anatomical constraints that support altered dFC in
baseline patients, as well as longitudinal changes of its
coupling with dFC. In particular, the SC with altered FC
variability in baseline patients will be explored, so that we
can focus the longitudinal changes of SC–dFC coupling
on individual connection. Based upon the previous evi-
dence supporting aberrant brain connectivity in schizo-
phrenia, we hypothesized that: (1) the altered dFC in
baseline patients is modified by treatment and tracks the
improvement of psychopathologic scores; and (2) SC
constrains altered dFC and their relationships at baseline
in patients is modulated by antipsychotic treatment.
Materials and methods
Participants
Forty-six patients with FEDN schizophrenia and 32
matched healthy volunteers were recruited from the
Shanghai Mental Health Center (SMHC) and local com-
munity. All the patients fulfilled the DSM-5 diagnostic
criteria for schizophrenia, and all of them did not have any
form of antipsychotic treatment prior to the initial scan.
The detailed inclusion and exclusion criteria are described
in Supplementary materials and Fig. S1. This study was
approved by the Institutional Review Board of SHMC.
Medication and clinical assessments
The patients with FEDN schizophrenia were treated
with second-generation antipsychotic (SGAs) for 8 weeks
following the guidelines according to refs. 38,39. Detailed
information of medication and dosage for each patient is
available in Table S1. The psychopathological symptoms
of each patient were measured using the PANSS40.
Image acquisition and preprocessing
All MRI data including T1-weighted, resting-state fMRI,
and diffusion-weighted imaging (DWI) were acquired on
a 3.0T Siemens Tim Verio scanner (Siemens, Germany) at
SMHC. Patients were scanned both at baseline and
8 weeks follow-up, and healthy controls were scanned
only at baseline. Participants were instructed to stay
awake with their eyes closed, to remain still, and not to
think systematically during the scan. Functional images
were preprocessed using the DPARSF toolbox41, includ-
ing removal of the 5 initial volumes, slice-timing, rea-
lignment, normalization, and spatial smoothing. Diffusion
images were preprocessed using the PANDA toolbox42,
which included estimating the brain mask, cropping the
raw images, correcting for the eddy-current effect, and
calculating diffusion metrics. Of note, to account for
artifact of head motion, any data affected by head motion
(maximal motion between volumes in each direction is
greater than 1.5 mm, and rotation in each axis is greater
than 1.5°) were discarded. We also calculated the mean
frame-wise displacement (FD) of each participant on the
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basis of realignment parameters and the participants with
FD more than 0.2 mm were excluded. After head motion
exclusion, 34 patients and 28 controls at baseline and 24
patients at follow-up were included in the subsequent
analysis. Greater details of data preprocessing and criteria
for significant head motion are provided in Supplemen-
tary methods. The analysis framework of this study is
shown in Fig. S2.
Group independent component analysis
To identify the intrinsic connectivity networks (ICNs)
and their corresponding time courses, we parcellated the
fMRI data using a standard pipeline for spatial group
independent component analysis (ICA)43,44, including
principal component analysis (PCA) to reduce subject-
specific data, informax algorithm analysis to further
reduce the concatenated subject-reduced data into inde-
pendent components (ICs)45, back reconstruction from
group spatial maps to subject-specific spatial maps and
estimate the corresponding time courses via group ICA
approach. Of note, the global signal regression was per-
formed as the standard PCA processing step prior to ICA
implemented by GIFT toolbox. The ICA process resulted
in 36 ICNs that were categorized into 7 resting-state
networks (RSNs) including sub-cortical (SUC; 2 ICNs),
auditory (AUD; 2 ICNs), visual (VIS; 5 ICNs), somato-
motor (SM; 9 ICNs), cognitive control (CC; 9 ICNs),
default mode (DM; 7 ICNs), and cerebellar (CB; 2 ICNs)
networks. The activation information spatial maps of
these ICNs are presented in Table S2 and Fig. S3. Addi-
tionally post-processing steps were performed on the time
courses of the 36 ICNs to remove remaining noise sour-
ces, including detrending linear, quadratic and cubic sig-
nals, conducting regressions of the 6 realignment
parameters and their temporal derivatives, despiking
detected outliers, and low-pass filtering with a cutoff
frequency of 0.15 Hz. See Supplementary materials for
more details.
Dynamic functional connectivity estimation
A previously validated sliding window approach was
used here to estimate dFC. Here, the time courses of ICNs
were divided into a window with 22 TRs length and 1 TR
increment-step, resulting in a total of 153 windows across
the entire scan for each participant. Of note, we used the
window length of 22 TRs since it has been demonstrated
to provide a good cutoff between the quality of the cor-
relation matrix estimation and the ability of to detect
functional dynamics16. A 36 × 36 covariance matrix within
each window was calculated to construct FC networks46,
wherein each ICN was defined as a node and the con-
nectivity between two ICNs was defined as an edge. An L1
norm in the graphic LASSO framework with 100 repeti-
tions47 was further conducted to promote sparsity in
estimation. The obtained FC matrices were then con-
verted to z-scores using Fisher’s z-transformation and
residualized with nuisance variables. The resulting 153
matrices for each participant represent the dynamic
changes of FC networks over time. Since previous studies
have suggested that dynamic connectivity patterns could
be captured stably in the range of 30–60 s16,48, we verified
the findings by testing other window sizes (18–26 TRs).
Dynamic functional connectivity analysis
We then performed a systematical analysis to explore
the treatment-related reorganization of dFC at multiple
topological scales, ranging from the whole network to
individual connectivity edges, with focus on the temporal
properties of dFC states, dynamic network efficiency, and
temporal variability of FC.
Temporal properties of dFC states
A k-means clustering analysis was initially performed
on the dFC matrices of all participants to estimate reoc-
curring dFC states. The similarity between matrices and
cluster centroids was measured using the L1 distance
function49. The optimal number of clusters= 5 was esti-
mated by using the elbow criterion18. The obtained group
centroids were used as the initial centroids to cluster each
participant’s windowed FC matrices. Of note, a state was
considered as a reliable state when it covered at least 10
windows. Additionally, we conducted a k-means cluster-
ing analysis with other numbers of clusters (k= 4, 6) to
verify the findings in this study. The temporal properties
of dynamic states were then evaluated using a measure of
state occurrence rate (the proportion of time spent in
each state). A Mann–Whitney U-test was used to test the
significance of a state occurrence between baseline patient
and control groups, and a paired t-test was conducted
between patients at baseline and follow-up. A FDR-
corrected P < 0.05 was considered as significant.
Dynamic network efficiency
A network efficiency approach was then applied to
examine the temporal variability of the topological orga-
nization of large-scale brain networks at both global and
local level. Efficiency was calculated at a several sparsity
thresholds from 0.1 to 0.35 according to ref. 43. The area
under the curve (AUC) within the defined threshold range
for each measure of efficiency was estimated. The var-
iance on the AUC changes across 153 windows was cal-
culated to examine dynamic topology properties of the FC
networks24. The graph theory analyses were performed
with GRETNA software (http://www.nitrc.org/projects/
gretna). A Wilcoxon rank test was used to test the group
difference in dynamic network efficiency (P < 0.05, FDR-
corrected).
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Temporal variability of FC
The temporal variability of FC was measured by cal-
culating the FC variance in each pair of ICNs across all
windows, which plays a key role in dynamically inte-
grating and coordinating neural systems50,51. Then the
Network Based Statistics (NBS)52 was used to identify
whether there was a group difference in connectome-
based FC variability by comparing the baseline patient
and control groups. Different from traditional statistical
analysis, the NBS handles the multiple comparisons
problem of the multiple edges in connectomic data by
evaluating the null hypothesis at the level of inter-
connected sub-networks rather than individual con-
nections52. NBS inference was by permutation testing
using unpaired t tests with 5000 permutations. A test
statistic was then computed for each connection, and a
threshold of t= 2.708 was applied to identify a set of
supra-threshold connections that showed significant
differences in FC variability between baseline patient
and control groups (significance at P<0.05, FDR-cor-
rected). To examine the longitudinal changes of FC
variability after treatment, we used a paired t-test to test
the group difference between patients at baseline and
follow-up with permutation inference (P < 0.05, FDR-
corrected).
SC–dFC association analysis
To observe how the anatomical constraints of altered
dFC change in response to treatment, we used DWI to
inform the SC between pairs of ICNs that showed altered
FC variability in baseline patients. We transformed the
ICNs in the MNI space to the native DWI space of each
participant. First, the ICBM 152 template was registered
to the b0 image of each participant in native DWI space
using linear and nonlinear registration in FSL. Then,
atlases from ICNs were transformed to each participant’s
native space with nearest-neighbor interpolation. White
matter tracts were traced using a whole-brain determi-
nistic tractography approach, which was performed in the
native space for each participant using the fiber assess-
ment by continuous tracking (FACT) algorithm. Here,
fiber tracking was terminated when the angle between two
consecutive orientations was >45º or when the FA value
was <0.2. In line with previous studies36, the number of
diffusion streamlines connecting pairs of regions was used
as a measure of SC weights, which has been demonstrated
as effective in detecting anatomical abnormalities both in
first-episode and chronic schizophrenia patients53,54. The
strength of coupling between SC and dFC was examined
by computing the level of Spearman’s correlation between
the weights of existing SC and its dFC counterparts. This
correlation is referred to as the level of SC–dFC coupling
(P < 0.05). Detailed information of SC estimation is pro-
vided in Supplementary methods.
Clinical and psychological data analysis
Group differences in demographics were explored using
a two-sample t-test (age and education) and a chi-square
test (gender). Differences in PANSS scores between
patients at baseline and follow-up were examined using a
paired t-test. Furthermore, we carried out Spearman’s
correlation analyses to investigate the relationships
between alterations in brain measures (dFC and SC) and
PANSS scores as well as between their longitudinal
changes in schizophrenia patients, controlling for age,
gender, mean frame-wise displacement, and daily dose of
antipsychotic medication. Statistical analyses were per-
formed using SPSS 24.0 (IBM Corporation, Armonk, NY,
USA) and statistical significance was set at P < 0.05 with
FDR-correction.
Results
Demographic and clinical characteristics
Healthy controls and patients at baseline did not differ
in age, gender, and education (all tests P > 0.05). The
mean duration since onset of psychiatric symptoms for
baseline patients was 6.7 months (SD= 11.9). After
8 weeks of antipsychotic treatment, we found a significant
reduction on PANSS total score, positive symptoms,
negative symptoms, and general symptoms (P < 0.0001).
Detailed demographic and clinical characteristics of the
included participants are shown in Table 1.
Occurrences of dFC patterns
The cluster centroid of 5 dFC states across participants
is shown in Fig. 1. Supplementary Fig. S4 shows group-
specific cluster centroids for each state. Compared with
controls, baseline patients showed a lower occurrence rate
in State 5 (P= 0.0098, FDR-corrected), which exhibited
strongly positive couplings between AUD and VIS, and
SM networks as well as between VIS and SM networks,
representing a high sensory-network interaction state. We
then investigated the longitudinal changes of state
occurrence in response to antipsychotic treatment and
observed that the occurrence rate in State 3 was sig-
nificantly increased in patients after treatment compared
with that at baseline (P= 0.0058). State 3 exhibited
strongly positive couplings among SUC, AUD, SM, and
CC, as well as negative DM couplings with SUC, AUD,
SM, and CC, representing a strong inter-network inte-
gration state. Spearman’ correlation analysis further
showed that the increased occurrence rate in State 3 was
significantly related with decreased PANSS score after
treatment. Moreover, we found that these findings were
independent of different settings of sliding window (Figs.
S5, S6) and clusters (Figs. S7, S8), and global signal (Fig.
S9), indicating a medication-induced intrinsic reorgani-
zation of dFC that were associated with relief of psychotic
symptoms after treatment.
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Temporal variability of dFC
We investigated the dynamic network efficiency in
time-varying functional brain networks and found
insignificant difference between both groups at baseline
(Fig. S10). We then explored the schizophrenia-related
alterations of FC variability and revealed a pre-treatment
connectomic signature that showed a significant differ-
ence in FC variance between both groups at baseline
(SZ_b < HC; P= 0.016, FEW-corrected). This signature
was characterized by lower FC variability within DM and
CC as well as between multiple other RSNs (i.e., DM and
AUD, SM, CC, CB; CC and AUD, CB; SM and VIS, CB)
(Fig. 2). Moreover, we observed that the FC variability of
this signature was increased in patients after treatment
compared with that at baseline, although the group dif-
ference showed a marginally statistical significance (P=
0.058).
We further evaluated the association between FC
variability and clinical measures in patients. There was no
significant correlation at baseline (r=−0.11, P= 0.5234),
but a significantly negative correlation at follow-up (r=
−0.41, P= 0.0439). Importantly, we observed that
increased FC variability was significantly correlated with
decreased PANSS total score after treatment (r= 0.53, P
= 0.0080). Further analysis indicated that the significant
correlations (P < 0.05) involved the intro-network con-
nections of DM, as well as the inter-network connections
between AUD, CC, and CB to other RSNs (Fig. 3). These
analyses suggest that relief of psychotic symptoms in
patients after treatment is associated with increased FC
variability within and between specific brain networks.
Association between dFC and SC
To investigate the longitudinal changes in SC that sup-
port altered dFC in baseline patients, we tracked the
number of DWI streamlines connecting pairs of ICNs
identified as connectomic signatures as having lower FC
variability. We found that the number of reconstructed
streamlines between IC94 (SFG) and IC97 (MPFC) was
significantly decreased in patients after treatment com-
pared with that baseline (P= 0.0023) (Fig. 4). Additionally,
decreased fiber numbers were negatively correlated with
decreased PANSS scores after treatment (r=−0.39, P=
0.0579). We further observed the relationships in the SFG-
MPFC connection between FC variability and number of
fiber streamlines for each group. A significant association
between FC variability and number of fiber streamlines
was found at baseline in patients (r=−0.37, P= 0.0324),
while this relationship was not present in controls (r=
−0.16, P= 0.4101) or treated patients (r=−0.31, P=
0.1285), suggesting a decoupling of SC and dFC for schi-
zophrenia patients in response to antipsychotic treatment.
Discussion
In this study, we performed a systematical dFC analysis
to investigate how antipsychotic medication modifies large-
scale brain networks in FEDN schizophrenia and how these
alterations relate to changes in symptoms. The present
results establish a significant relationship between brain
networks and clinical relief. Specifically, the longitudinal
changes of dFC state occurrence and FC variability
emerged as key indicators of symptomatic improvement in
schizophrenia. Moreover, SC association analyses indicate
Table 1 Demographics and clinical characteristics from study groups.
SZ_b (n= 34) SZ_p (n= 24) HC (n= 28) SZ_b verses HC (P-value) SZ_bp verses SZ_p (P-value)
Age (y) 27.1 ± 6.1 27.4 ± 5.7 27.1 ± 4.5 0.99c \
Gender (f) 17 12 15 0.78d \
Handedness (l/r) 0/34 0/24 0/28 \ \
Education (y) 12.9 ± 3.2 13.2 ± 3.2 14.4 ± 2.2 0.06c \
aDUP (m) 6.7 ± 11.9 \ \ \ \
bAntipsychotic dose(in CPZE, mg) \ 339.6 ± 137.5 \ \ \
PANSS total score 74.0 ± 17.8 48.3 ± 14.0 \ \ <0.0001e
positive symptoms 20.3 ± 5.3 11.0 ± 3.6 \ \ <0.0001e
negative symptoms 16.6 ± 6.1 12.3 ± 4.8 \ \ <0.0001e
general symptoms 37.1 ± 9.4 25.0 6.7 \ \ <0.0001e
Values are mean ± SD or N.
y year, f female, m month, l left, r right, DUP duration of untreated psychosis.
aDUP of each FEDN schizophrenia patient was determined by psychiatrists from the disease onset until the first clinical examination.
bThe daily antipsychotic dose converted to chlorpromazine equivalents (CPZE).
cStatistical differences were obtained using two-sample t-test.
dStatistical differences were obtained using Chi-square test.
eStatistical differences were obtained using paired t-test.
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that the anatomical constraints to support dFC and their
association were modified longitudinally by antipsychotic
treatment. Thus, the present work provides the novel evi-
dence for neurobiological mechanisms of antipsychotic
treatment that lead to symptomatic improvement, and
underscore the potential of dynamic functional brain net-
works in searching prognostic markers and predicting
treatment response of schizophrenia.
Occurrence of dFC patterns changes longitudinally and
tracks symptomatic improvement
Our results demonstrated significant group differences
in the occurrence of dFC states. That the baseline
patients spent much less time than controls in State 5 is
consistent with prior findings in chronic schizo-
phrenia18,20,22. State 5 was characterized by strong
interactions between sensory networks, and it represents
a state of low alertness or drowsiness in the human
brain16. The lower occurrence of this state may reflect an
excessive level of arousal or an inability to be in relaxa-
tion that may lead to diverse symptoms of schizo-
phrenia22. It can be supported by the relationships
established in our study, where the lower occurrence in
State 5 was linked to more severe clinical symptoms (Fig.
S11). More importantly, we found that the occurrence of
State 3 in patients after treatment was higher than
baseline. This finding is partly consistent with a previous
work that the dwell time of dFC states was changed in
patients with chronic schizophrenia after 6 weeks of
risperidone treatment11. Specifically, state 3 was char-
acterized by stronger positive couplings among multiple
networks (i.e. SC, AUD, SM and CC), as well as negative
correlations between DM and these networks. The
increased occurrence of this state may reflect a reinforced
global integration of the brain networks in patients after
treatment and thus contribute to the improvement of
psychosis symptoms. Our results could also be inter-
preted as a potential compensatory mechanism of dFC
Fig. 1 Dynamic functional connectivity patterns and association with psychosis symptoms. A Five discrete dynamic functional connectivity
patterns across all groups. The percentage of occurrences is listed above each cluster centroid. The color bar represents z values of functional
connectivity (FC). B Differences in state occurrences between baseline schizophrenia patient (SZ_b) and healthy control (HC) groups. C Group
differences in state occurrences between post-treatment (SZ_p) and paired baseline patients (SZ_bp). D Associations between changed occurrences
of the State 3 and improved psychosis symptoms after treatment. **P < 0.01, FDR-corrected.
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states in response to antipsychotic treatment, where
antipsychotic drugs did not normalize the occurrence of a
strong sensory-network interaction state, but instead
enhanced the expression of a strong inter-network inte-
gration state. Future studies are required to clarify the
relevance of these dFC states, particularly State 3, with
brain cognitive states, as well as their neurophysiological
mechanism in response to antipsychotic treatment.
FC variability changes longitudinally and tracks
symptomatic improvement
Our findings of a baseline deficit in dFC variability in
patients are consistent with a report of reduced FC dyna-
mism in clinical high-risk individuals for schizophrenia55. It
has been suggested that a higher FC variability may reflect a
greater complexity and greater capacity for information
processing26,56,57. Thus, the lower FC variability we
observed may indicate decreased ability for information
processing in patients. Moreover, we found that FC varia-
bility of this connectomic signature was increased in
patients with greater symptomatic reduction after treat-
ment, suggesting a medication-induced normalization.
Indeed, the findings of time-invariant FC studies have
reported that successful treatment is often linked to the
normalization of regional FC9,13. It is therefore intriguing to
assume that the increases in FC variability caused by
antipsychotic medications may modulate the corresponding
spatiotemporal changes on the psychological level which, in
turn, improve psychosis symptoms, corresponding to what
has been described as “Spatiotemporal Psychopathol-
ogy”58,59. Further results demonstrated that the sympto-
matic improvement-related FC variability in this signature
was mainly involved with intra-network connections of DM
and inter-network connections of AUD, CC, and CB, which
are well known to be implicated in schizophrenia. Specifi-
cally, dysfunction in the DMmay lead to the disturbances of
self-referential processing in patients60. Convergent evi-
dence has linked symptomatic improvement to FC changes
within the DM9,13,61. Consistently, our increased FC varia-
bility within the DM suggest that self-related thought plays
a pivotal role in recovery from psychosis symptoms. Addi-
tionally, dysconnectivity of the primary sensory networks
(e.g., AUD and CB) with other high-order cognitive net-
works (e.g., CC) is considered to be related to symptoms
such as hallucinations and emotional dysregulation62–65,
and abnormal CC connectivity to other networks might
lead to various executive control deficits in patients with
schizophrenia66,67. Overall, our findings, therefore, provide
solid evidence supporting that symptomatic reduction in
response to antipsychotic treatment is associated with
normalization of FC variability in multiple large-scale net-
works implicated in the pathophysiology of schizophrenia.
Fig. 2 The connectomic signature and association with psychosis symptoms. A, B The functional connectomic signature was identified by
using the NBS at baseline (SZ_b < HC). C Group differences in FC variability of this signature. D Associations between FC variability and psychosis
symptoms. ***P < 0.001, ★P= 0.058, FDR-corrected.
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SC–dFC coupling changes longitudinally
A particularly important objective of our study was to
explore whether the structure underpinnings of altered
FC variability in baseline patients and their relationship
can be modulated by antipsychotic treatment. It has been
suggested that antipsychotic medications have an effect
Fig. 3 Associations between altered FC variability of intra- and inter-RSNs and relief of psychosis symptoms. Significance, P < 0.05, FDR-
corrected.
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on myelin content, thus changing whiter matter (WM)
microstructure. Studies using DTI have frequently
revealed WM tract changes in relation to 6–12 weeks of
antipsychotic exposure, ranging from white matter
integrity to network topologic organization54,68–70. Our
results add to previous findings, suggesting that the SC
between the SFG and MPFC can be modulated by phar-
macological intervention, especially during the early phase
of treatment. However, it is not possible to entirely
exclude the influences of underlying progression of ill-
ness. We also observed that symptom reduction was anti-
correlated with decreased SC between the SFG and
MPFC, suggesting that antipsychotic drugs might
attenuate clinical features of schizophrenia by delaying the
reduction of WM tracts. Our results can be supported by
previous findings that antipsychotic-treated patients
exhibited much less reduction of fractional anisotropy
than never-treated patients in brain structure71. More-
over, we observed that the FC variability between the SFG
and MPFC was negatively correlated with its SC coun-
terparts in baseline patients, but this relationship was lost
after treatment, suggesting that antipsychotic treatment
may induce a decoupling of SC–dFC on this connection.
Contemporary theories have suggested that aberrant
relationships of SC and (static) FC could lead to deficits in
executive function as well as the emergence of neu-
ropsychiatric disorders such as schizophrenia36,72–74. In
this study, we extend these findings by showing a tightly
coupled SC and dFC at baseline in patients, which reflects
a less dynamic or more stringent functional commu-
nication between the SFG and MPFC, may be directly
constrained by its underlying white matter structure.
Echoing the triple-network hypothesis of schizo-
phrenia75,76, the decoupling after treatment suggests an
increased functional flexibility and dynamic recruitment
to balance internally generated thoughts and externally
stimulated executive processing77,78, and thus contribute
to the relief of psychotic symptoms in schizophrenia
patients.
Clinical implications
Our findings may contribute to the future therapy for
schizophrenia in the following two aspects. First, our
study sheds light on the neural pathophysiology under-
lying therapeutic effects of antipsychotic treatment.
Although attempts have been made to determine
neuroimaging-based biomarkers that relate to treatment
response, the findings are inconsistent6–12. Our study,
from the perspective of large-scale brain networks, pro-
vides a new avenue for exploring potential markers of
treatment that contribute to symptom reduction. Second,
our study provides important information in the search
for clinically useful prognostic markers of schizophrenia.
Recently, many researchers have examined whether brain
connectivity can be used to predict response to anti-
psychotic treatment54,79–82. In our study, we used baseline
dFC features to predict symptomatic improvement after
treatment. Our results indicate that the dFC features can
Fig. 4 Structural connectivity association analyses. A Spatial maps of two components (SFG and MPFC). B Differences in number of diffusion
streamlines in patients between baseline (SZ_p) and follow-up (SZ_bp). C Decreased number of streamlines between the SFG and MPFC were
marginally negatively correlated with decreased PANSS scores in patients after treatment. D Relationship between FC variability and number of
streamlines in each groups. **P < 0.01. SFG= superior frontal gyrus; MPFC=medial prefrontal cortex.
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significantly improve prediction performance compared
to models using demographic and clinical measures alone.
Specifically, we obtained the cross-validated accuracy of a
model without dynamic features/with dynamic features=
0.40/0.55, P= 0.0552/0.0052 (Fig. S12). Given the limited
sample sizes in our study, however, this high prediction
performance should be verified in further longitudinal
research.
Limitations
Our study was subject to a few limitations that deserve
mention. First, to investigate the changes caused by direct
antipsychotic treatment rather than a potential effect of
the disease itself, we opted for a modest homogeneous
cohort of FEDN schizophrenia instead of a large hetero-
geneous cohort. Our patients are older than the patients
included in previous studies82,83. Future study with a
larger and younger homogeneous cohort is needed to
validate our findings. Second, all patients were treated
with the SGA medication. However, previous findings
have suggested that different antipsychotic agents vary in
their potency and effects on brain structure and function3.
It would be important for a further study to determine
whether the changes observed here were general or spe-
cific across different types of antipsychotics. Third,
although our study has focused on the structural under-
pinnings of a connectomic signature with lower FC
variability, it has been suggested that medication-induced
SC changes can be preserved between brain regions that
show normal functional coupling. That means the
alterations of SC–dFC coupling after treatment can be
found even on the connections outside the connectomic
signature. Therefore, future studies in schizophrenia
should measure the treatment-induced changes in whole-
brain SC–dFC coupling.
In conclusion, our study investigated the modification
of large-scale brain networks caused by antipsychotic
medications in FEDN schizophrenia. We have shown, for
the first time, that longitudinal changes of occurrence of
dFC states and FC variability can track symptomatic
improvement in response to antipsychotic treatment.
Furthermore, the SC constraints of altered dFC, as well as
their relationships, are longitudinally altered by medica-
tions. Overall, these findings demonstrate that anti-
psychotic treatment can ease psychotic symptoms by
modulating large-scale brain networks, which opens up
new avenues to develop a target for novel therapeutic
interventions and to identify an indicator of long-term
prognosis.
Acknowledgements
This work was supported by the National Natural Science Foundation of China
(No. 81801785 and 81871047), by Key Program of Multidisciplinary Cross
Research Foundation of Shanghai Jiao Tong University (No. YG2017ZD13), by
Key Program of Shanghai Mental Health Center Clinical Research Center (No.
CRC2017ZD03), by Shanghai Key Laboratory of Psychotic Disorders (No.
13dz2260500), by the “Hundred Talents Program” of Zhejiang University, by the
Fundamental Research Funds for the Central Universities (No. 2019FZJD005
and 2020FZZX001-05), by the Zhejiang Lab (No. 2019KE0AD01), by the China
Postdoctoral Science Foundation (No. 2020M681865), and by Gansu Province
Universities and Colleges Scientific Research Project (No. 2018A-124).
Author details
1Key Laboratory for Biomedical Engineering of Ministry of Education,
Department of Biomedical Engineering, Zhejiang University, Zhejiang, China.
2First-episode Schizophrenia and Early Psychosis Program, Division of Psychotic
Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University
School of Medicine, Shanghai, China. 3Department of Neurology, Sir Run Run
Shaw Hospital, Zhejiang University School of Medicine, Zhejiang, China. 4Brain
Mapping Unit, Department of Psychiatry, School of Clinical Medicine, Herchel
Smith Building for Brain and Mind Sciences, University of Cambridge,
Cambridge, UK. 5Department of Medical Imaging, Shanghai Mental Health
Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
6Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health
Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
7Institute of Mental Health, Fudan University, Shanghai, China. 8Zhejiang Lab,
Zhejiang, China
Data availability
The data that support the findings of this study are available from the
corresponding author, upon reasonable request.
Conflict of interest
The authors declare no competing interests.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Supplementary information The online version contains supplementary
material available at https://doi.org/10.1038/s41398-021-01398-4.
Received: 13 January 2021 Revised: 9 April 2021 Accepted: 20 April 2021
References
1. McCutcheon, R. A., Reis Marques, T. & Howes, O. D. Schizophrenia—an
overview. JAMA Psychiatry 77, 201–210 (2019).
2. Boter, H. et al. Effectiveness of antipsychotics in first-episode schizophrenia
and schizophreniform disorder on response and remission: an open rando-
mized clinical trial (EUFEST). Schizophr. Res 115, 97–103 (2009).
3. Tarcijonas, G. & Sarpal, D. K. Neuroimaging markers of antipsychotic treatment
response in schizophrenia: an overview of magnetic resonance imaging
studies. Neurobiol. Dis. 131, 104209 (2019).
4. Kane, J. M. & Correll, C. U. Past and present progress in the pharmacologic
treatment of schizophrenia. J. Clin. Psychiatry 71, 1115–1124 (2010).
5. Remington, G. et al. Treating negative symptoms in schizophrenia: an update.
Curr. Treat. Options Psychiatry 3, 133–150 (2016).
6. Anticevic, A. et al. Early-course unmedicated schizophrenia patients exhibit
elevated prefrontal connectivity associated with longitudinal change. J. Neu-
rosci. 35, 267–286 (2015).
7. Kraguljac, N. V. et al. Aberrant hippocampal connectivity in unmedicated
patients with schizophrenia and effects of antipsychotic medication: a long-
itudinal resting state functional MRI study. Schizophr. Bull. 42, 1046–1055
(2016).
8. Sarpal, D. K. et al. Antipsychotic treatment and functional connectivity of the
striatum in first-episode schizophrenia. JAMA Psychiatry 72, 5–13 (2015).
9. Guo, W. et al. Treatment effects of olanzapine on homotopic connectivity
in drug-free schizophrenia at rest. World J. Biol. Psychiatry 19, S106–S114
(2018).
10. Kraguljac, N. V. et al. Abnormalities in large scale functional networks in
unmedicated patients with schizophrenia and effects of risperidone. Neuro-
Image. Clin. 10, 146–158 (2016).
Zhang et al. Translational Psychiatry          (2021) 11:282 Page 10 of 12
11. Lottman, K. K. et al. Risperidone effects on brain dynamic connectivity-a
prospective resting-state fmri study in schizophrenia. Front. psychiatry 8, 14
(2017).
12. Lui, S. et al. Short-term effects of antipsychotic treatment on cerebral function
in drug-naive first-episode schizophrenia revealed by "resting state" functional
magnetic resonance imaging. Arch. Gen. Psychiatry 67, 783–792 (2010).
13. Wang, Y. et al. Resting-state functional connectivity changes within the default
mode network and the salience network after antipsychotic treatment in
early-phase schizophrenia. Neuropsychiatr. Dis. Treat. 13, 397–406 (2017).
14. Calhoun, V. D., Miller, R., Pearlson, G. & Adali, T. The chronnectome: time-
varying connectivity networks as the next frontier in fMRI data discovery.
Neuron 84, 262–274 (2014).
15. Calhoun, V. D. & Adali, T. Time-varying brain connectivity in fmri data: whole-
brain data-driven approaches for capturing and characterizing dynamic states.
IEEE Signal Process. Mag. 33, 52–66 (2016).
16. Allen, E. A. et al. Tracking whole-brain connectivity dynamics in the resting
state. Cereb. Cortex 24, 663–676 (2014).
17. Lurie, D. J. et al. Questions and controversies in the study of time-varying
functional connectivity in resting fMRI. Netw. Neurosci. 4, 30–69 (2020).
18. Damaraju, E. et al. Dynamic functional connectivity analysis reveals transient
states of dysconnectivity in schizophrenia. NeuroImage. Clin. 5, 298–308 (2014).
19. Miller, R. L. et al. Higher dimensional meta-state analysis reveals reduced
resting fMRI connectivity dynamism in schizophrenia patients. PLoS ONE 11,
e0149849 (2016).
20. Rabany, L. et al. Dynamic functional connectivity in schizophrenia and autism
spectrum disorder: convergence, divergence and classification. NeuroImage.
Clin. 24, 101966 (2019).
21. Salman, M. S., Vergara, V. M., Damaraju, E. & Calhoun, V. D. Decreased cross-
domain mutual information in schizophrenia from dynamic connectivity
states. Front. Neurosci. 13, 873 (2019).
22. Weber, S. et al. Dynamic functional connectivity patterns in schizophrenia and
the relationship with hallucinations. Front. Psychiatry 11, 227 (2020).
23. Sun, Y., Collinson, S. L., Suckling, J. & Sim, K. Dynamic reorganization of func-
tional connectivity reveals abnormal temporal efficiency in schizophrenia.
Schizophr. Bull. 45, 659–669 (2019).
24. Yu, Q. et al. Assessing dynamic brain graphs of time-varying connectivity in
fMRI data: application to healthy controls and patients with schizophrenia.
NeuroImage 107, 345–355 (2015).
25. Dong, D. et al. Reconfiguration of dynamic functional connectivity in sen-
sory and perceptual system in schizophrenia. Cereb. Cortex 29, 3577–3589
(2019).
26. Guo, S., Zhao, W., Tao, H., Liu, Z. & Palaniyappan, L. The instability of functional
connectivity in patients with schizophrenia and their siblings: a dynamic
connectivity study. Schizophr. Res 195, 183–189 (2018).
27. Kottaram, A. et al. Spatio-temporal dynamics of resting-state brain networks
improve single-subject prediction of schizophrenia diagnosis. Hum. Brain
Mapp. 39, 3663–3681 (2018).
28. Duan, X. et al. Effect of risperidone monotherapy on dynamic functional
connectivity of insular subdivisions in treatment-naive, first-episode schizo-
phrenia. Schizophr. Bull. 46, 650–660 (2020).
29. Deco, G. et al. Resting-state functional connectivity emerges from structurally
and dynamically shaped slow linear fluctuations. J. Neurosci. 33, 11239–11252
(2013).
30. Honey, C. J. et al. Predicting human resting-state functional connectivity from
structural connectivity. Proc. Natl Acad. Sci. USA 106, 2035–2040 (2009).
31. Goni, J. et al. Resting-brain functional connectivity predicted by analytic
measures of network communication. Proc. Natl Acad. Sci. USA 111, 833–838
(2014).
32. Misic, B. et al. Network-level structure-function relationships in human neo-
cortex. Cereb. cortex 26, 3285–3296 (2016).
33. Camchong, J., MacDonald, A. W. 3rd, Bell, C., Mueller, B. A. & Lim, K. O. Altered
functional and anatomical connectivity in schizophrenia. Schizophr. Bull. 37,
640–650 (2011).
34. Yan, H. et al. Functional and anatomical connectivity abnormalities in cogni-
tive division of anterior cingulate cortex in schizophrenia. PLoS ONE 7, e45659
(2012).
35. Sun, Y., Dai, Z., Li, J., Collinson, S. L. & Sim, K. Modular-level alterations of
structure-function coupling in schizophrenia connectome. Hum. Brain Mapp.
38, 2008–2025 (2017).
36. van den Heuvel, M. P. et al. Abnormal rich club organization and functional
brain dynamics in schizophrenia. JAMA psychiatry 70, 783–792 (2013).
37. Cocchi, L. et al. Disruption of structure-function coupling in the schizophrenia
connectome. NeuroImage. Clin. 4, 779–787 (2014).
38. Taylor, D. M., Thomas, R. E. B. & Allan, H. Y. The Maudsley Prescribing Guidelines in
Psychiatry (John Wiley & Sons, 2018).
39. Kuipers, E. Schizophrenia: Core Interventions in the Treatment and Manage-
ment of Schizophrenia in Primary and Secondary Care (Update). (ed. Taylor C.
Leicester), (British Psychological Society, UK, 2009)
40. Kay, S. R., Fiszbein, A. & Opfer, L. A. The positive and negative syndrome scale
(PANSS) for schizophrenia. Schizophrenia Bull. 13, 261–276 (1987).
41. Yan, C. & Zang, Y. DPARSF: A MATLAB Toolbox for "Pipeline" data analysis of
resting-state fMRI. Front. Syst. Neurosci. 4, 13 (2010).
42. Cui, Z., Zhong, S., Xu, P., He, Y. & Gong, G. PANDA: a pipeline toolbox for
analyzing brain diffusion images. Front. Hum. Neurosci. 7, 42 (2013).
43. Tu, Y. et al. Abnormal thalamocortical network dynamics in migraine. Neu-
rology 92, e2706–e2716 (2019).
44. Kim, J. et al. Abnormal intrinsic brain functional network dynamics in Parkin-
son’s disease. Brain 140, 2955–2967 (2017).
45. Bell, A. J. & Sejnowski, T. J. An information-maximization approach to blind
separation and blind deconvolution. Neural Comput. 7, 1129–1159 (1995).
46. Smith, S. M. et al. Network modelling methods for FMRI. NeuroImage 54,
875–891 (2011).
47. Friedman, J., Hastie, T. & Tibshirani, R. Sparse inverse covariance estimation
with the graphical lasso. Biostatistics 9, 432–441 (2008).
48. Hutchison, R. M. et al. Dynamic functional connectivity: promise, issues, and
interpretations. NeuroImage 80, 360–378 (2013).
49. Aggarwal, C. C., Hinneburg, A. & Keim, D. A. On the Surprising Behavior of
Distance Metrics in High Dimensional Space (Springer, New York, NY, 2001).
50. Qin, Y. et al. BOLD-fMRI activity informed by network variation of scalp EEG in
juvenile myoclonic epilepsy. Neuroimage Clin. 22, 101759 (2019).
51. Hutchison, R. M., Womelsdorf, T., Gati, J. S., Everling, S. & Menon, R. S. Resting-
state networks show dynamic functional connectivity in awake humans and
anesthetized macaques. Hum. Brain Mapp. 34, 2154–2177 (2013).
52. Zalesky, A., Fornito, A. & Bullmore, E. T. Network-based statistic: identifying
differences in brain networks. NeuroImage 53, 1197–1207 (2010).
53. van den Heuvel, M. P., Scholtens, L. H., de Reus, M. A. & Kahn, R. S. Associated
microscale spine density and macroscale connectivity disruptions in schizo-
phrenia. Biol. Psychiatry 80, 293–301 (2016).
54. Crossley, N. A. et al. Connectomic correlates of response to treatment in first-
episode psychosis. Brain 140, 487–496 (2017).
55. Mennigen, E. et al. Reduced higher-dimensional resting state fMRI dynamism
in clinical high-risk individuals for schizophrenia identified by meta-state
analysis. Schizophr. Res. 201, 217–223 (2018).
56. Marusak, H. A. et al. Dynamic functional connectivity of neurocognitive net-
works in children. Hum. Brain Mapp. 38, 97–108 (2016).
57. Wang, J. et al. Abnormal intrinsic brain functional network dynamics in
unmedicated depressed bipolar II disorder. J. Affect. Disord. 253, 402–409
(2019).
58. Northoff, G. & Duncan, N. W. How do abnormalities in the brain’s spontaneous
activity translate into symptoms in schizophrenia? From an overview of
resting state activity findings to a proposed spatiotemporal psychopathology.
Prog. Neurobiol. 145-146, 26–45 (2016).
59. Northoff, G. et al. Too fast or too slow? Time and neuronal variability in bipolar
disorder—a combined theoretical and empirical investigation. Schizophr. Bull.
44, 54–64 (2018).
60. Whitfield-Gabrieli, S. & Ford, J. M. Default mode network activity and con-
nectivity in psychopathology. Annu Rev. Clin. Psychol. 8, 49–76 (2012).
61. Sambataro, F. et al. Treatment with olanzapine is associated with modulation
of the default mode network in patients with Schizophrenia. Neuropsycho-
pharmacology 35, 904–912 (2010).
62. Curcic-Blake, B. et al. Interaction of language, auditory and memory brain
networks in auditory verbal hallucinations. Prog. Neurobiol. 148, 1–20 (2017).
63. He, H. et al. Reduction in gray matter of cerebellum in schizophrenia and its
influence on static and dynamic connectivity. Hum. Brain Mapp. 40, 517–528
(2019).
64. Kim, N. Y. et al. Lesions causing hallucinations localize to one common brain
network. Mol. Psychiatry 26, 1299–1309 (2021).
65. Valton, V. et al. Acquisition of visual priors and induced hallucinations in
chronic schizophrenia. Brain 142, 2523–2537 (2019).
66. Berman, R. A. et al. Disrupted sensorimotor and social-cognitive networks
underlie symptoms in childhood-onset schizophrenia. Brain 139, 276–291
(2016).
Zhang et al. Translational Psychiatry          (2021) 11:282 Page 11 of 12
67. McNabb, C. B. et al. Functional network dysconnectivity as a biomarker of
treatment resistance in schizophrenia. Schizophr. Res. 195, 160–167 (2018).
68. Luck, D. et al. Fronto-temporal disconnectivity and clinical short-term outcome
in first episode psychosis: a DTI-tractography study. J. Psychiatr. Res. 45,
369–377 (2011).
69. Serpa, M. H. et al. State-dependent microstructural white matter changes in
drug-naive patients with first-episode psychosis. Psychological Med. 47,
2613–2627 (2017).
70. Zeng, B. et al. Abnormal white matter microstructure in drug-naive first epi-
sode schizophrenia patients before and after eight weeks of antipsychotic
treatment. Schizophr. Res. 172, 1–8 (2016).
71. Xiao, Y. et al. White matter abnormalities in never-treated patients with long-
term schizophrenia. Am. J. Psychiatry 175, 1129–1136 (2018).
72. Baum, G. L. et al. Modular segregation of structural brain networks supports
the development of executive function in youth. Curr. Biol. 27, 1561–1572
(2017).
73. Di Martino, A. et al. Unraveling the miswired connectome: a developmental
perspective. Neuron 83, 1335–1353 (2014).
74. Stephan, K. E., Baldeweg, T. & Friston, K. J. Synaptic plasticity and dyscon-
nection in schizophrenia. Biol. Psychiatry 59, 929–939 (2006).
75. Menon, V. Large-scale brain networks and psychopathology: a unifying triple
network model. Trends Cogn. Sci. 15, 483–506 (2011).
76. Palaniyappan, L., Mallikarjun, P., Joseph, V., White, T. P. & Liddle, P. F. Regional
contraction of brain surface area involves three large-scale networks in schi-
zophrenia. Schizophr. Res. 129, 163–168 (2011).
77. Yeo, B. T. et al. Functional specialization and flexibility in human association
cortex. Cereb. Cortex 25, 3654–3672 (2015).
78. Baum, G. L. et al. Development of structure-function coupling in human brain
networks during youth. Proc. Natl Acad. Sci. USA 117, 771–778 (2020).
79. Cao, B. et al. Treatment response prediction and individualized identification of
first-episode drug-naive schizophrenia using brain functional connectivity.Mol.
Psychiatry 25, 906–913 (2020).
80. Doucet, G. E., Moser, D. A., Luber, M. J., Leibu, E. & Frangou, S. Baseline brain
structural and functional predictors of clinical outcome in the early course of
schizophrenia. Mol. Psychiatry 25, 863–872 (2020).
81. Sarpal, D. K. et al. Baseline striatal functional connectivity as a predictor of
response to antipsychotic drug treatment. Am. J. Psychiatry 173, 69–77 (2016).
82. Tarcijonas, G., Foran, W., Haas, G. L., Luna, B. & Sarpal, D. K. Intrinsic connectivity
of the globus pallidus: an uncharted marker of functional prognosis in people
with first-episode schizophrenia. Schizophr. Bull. 46, 184–192 (2020).
83. Kraguljac, N. V. et al. White matter integrity, duration of untreated psychosis,
and antipsychotic treatment response in medication-naive first-episode psy-
chosis patients. Mol. Psychiatry, https://doi.org/10.1038/s41380-020-0765-x
(2020).
Zhang et al. Translational Psychiatry          (2021) 11:282 Page 12 of 12
